17 June 2020
Australia’s MTP sector hit hard by COVID-19 but still plays critical role in response and pandemic research: New Report
A new report released today reveals the COVID-19 health crisis has had a significant negative impact across the medical technology, biotechnology and pharmaceutical (MTP) sector, including startups, SMEs, large local and multinational companies, researchers, universities, service providers, industry organisations and investors.
16 June 2020
MTPConnect is launching the $32 million Researcher Exchange and Development within Industry (REDI) initiative, working in collaboration with eight leading industry and research partners: ANDHealth, APR.Intern, the Bridge and BridgeTech programs, IMNIS, Medical Device Partnering Program (MDPP), MedTech Actuator, the George Institute for Global Health and the Victorian Comprehensive Cancer Centre (VCCC).
11 June 2020
MTPConnect, along with a cross-industry project team of AusBiotech, ANDHealth, Medical Technology Association of Australia (MTAA) and Medicines Australia, need your help to identify skills gaps in the medtech, pharma, biotech and digital health sectors so we can do more to support our industry’s growth into the future.
04 June 2020
Check out what the MTPConnect team has been up to in May!
04 June 2020
MTPConnect’s 2020 Seminar Series continues in June with our webinar ‘Charting Your Course – Commercialising Health Innovations'. This event on 30 June, will explore the pathway to successful commercialisation of health innovations.
01 June 2020
Are you an aspiring director in the MTP sector looking to get your board career started? MTPConnect is seeking it’s next Guest of the Chair for a 12 month appointment.
26 May 2020
Nucleus Network today announced the start of its Phase I/II clinical trial of a COVID-19 vaccine candidate at its Melbourne clinic, making it the first human trial for a vaccine in the Southern Hemisphere.
20 May 2020
Today, across the world, we laud the work of Dr James Lind. On this day in 1747, Lind started his famous scurvy experiments with oranges and lemons on board the HMS Salisbury.
15 May 2020
MTPConnect is set to launch a third round of its Biomedical Translation Bridge program, specifically designed to target COVID-19 related research.
13 May 2020
German Technology Service searching for Australian medtech companies developing anti-biofilm agents for wound care dressings
The German Technology Service is searching for new, active anti-biofilm agents for the treatment of wound biofilms in chronic wounds on behalf of a German medical technology group.
05 May 2020
Over the last few months, as the world has seen the COVID-19 health emergency unravel, there has been dramatic social and economic change. In a recent podcast episode, our podcast team – Dr Dan Grant and Stuart Dignam – asked our guest, economist Dr Pradeep Philip from Deloitte Access Economics: how will Australia navigate its medical research and innovation response in a world impacted by COVID-19?
04 May 2020
Check out what our MTPConnect team got up to in April!
29 April 2020
Therapeutic Innovation Australia opens up access to translational R&D facilities for COVID-19 Response
Does your research team need to access to translational R&D facilities to work on COVID-19 projects? If your team are up for the challenge, then this opportunity could be for you.
24 April 2020
MTPConnect’s 2020 Seminar Series is back with a program of webinars designed to showcase the latest ideas, issues and challenges for the medtech, biotech and pharmaceutical sector in Australia.
17 April 2020
The MTPConnect Podcast team is working to bring you insightful stories into how Australian companies and researchers are pivoting their activities to respond to COVID-19.